Asset sale Completed

J. Molner acquisition of US generic and specialty pharmaceutical product portfolio of Nordic Pharma

Announced Jun 2026 (approx.)

Advisers

US generic and specialty pharmaceutical product portfolio of Nordic Pharma

Target

Not disclosed

J. Molner

Acquirer

Not disclosed

Other advisers

Financial adviser
Target
US generic and specialty pharmaceutical product portfolio of Nordic Pharma
Acquirer
J. Molner
Seller
Nordic Pharma
Target based in
United States
Buyer based in
United States (unverified)
Seller based in
France (unverified)
Completed
Jun 2026
Sector
Pharma

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.